|
|
Article: Body Weight Key In Choice of PCOS Therapy.
- Article from:
- OB GYN News
- Article date:
- December 15, 2000
- Author:
CopyrightCOPYRIGHT 2000 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON -- Body weight is a crucial consideration in determining the choice of treatment for clomiphene-resistant women with polycystic ovary syndrome who wish to become pregnant, Dr. Alexander B. Mamonov said at the FIGO World Congress of Gynecology and Obstetrics.
Obese women showed a better response to laparoscopic electrocoagulation of the ovarian surface (LEOS), whereas lean women responded well to medical therapy with the follicle-stimulating hormone Metrodin in a study involving 128 women who had been infertile for a range of 2-8 years. The study cohort included 84 obese and 44 nonobese women, said Dr. Mamonov of Donetsk State Medical University, ...